We’re on a mission to
improve patient outcomes.

Shazia is a published machine learning engineer and researcher focused on applications of deep learning in medical imaging. She previously worked at the Vector Institute, Sunnybrook Health Sciences, and NYU Langone Medical Center. Shazia received her MS and PhD from the University of Dundee.

Felix is the co-founder and Chief Executive Officer of Altis Labs. Prior to founding Altis, Felix was a director at Enlitic, which pioneered the application of deep learning in radiological imaging and was twice selected one of MIT Technology Review's 50 Smartest Companies. At Enlitic, Felix led global business development, establishing partnerships with hospital networks and healthcare IT vendors in North America, Europe, and Asia. Previously, Felix conducted research on venture capital and private equity investments at Cambridge Associates and developed loss forecasting models for commercial lending portfolios at KPMG. Felix received his BA in economics from Colby College.

Lajhem is a product manager at Verana. Previously, she managed oncology trials across 21 hospitals at UCSF and was a clinical research supervisor at Memorial Sloan Kettering. She received her BA from Princeton, MS from Columbia, and MBA from Wharton.

John was global head of data sciences and chief R&D information officer at AstraZeneca, working to rebuild the scientific data environment. Previously, he was in scientific and commercial roles at companies including GSK, Merck, Schrödinger, Riffyn, and Accelrys.

Sally is an accomplished entrepreneur, lawyer, and executive. She founded ViXS, a graphics chip company that she scaled to over $100 million in annual revenue and took public. Sally has served as a board member of Hydro One, one of Canada’s largest utility companies, and Trillium Health Partners, Canada’s largest community hospital network. Sally is a chemical engineer, honorary PhD, and was four times named one of Canada’s 100 most powerful women.

Jay is an experienced clinical data engineer. He previously built imaging data pipelines and quality control tools at the Krembil Centre for Neuroinformatics to facilitate machine learning research. He received his MEng in biomedical engineering from McGill. 

Ahmed is pursuing his PhD under Dr. Hugo Aerts at Dana Farber Cancer Center. His published research focuses on the development of prognostic imaging biomarkers for lung cancer using deep learning.

Matt is an experienced medical imaging software engineer. He was previously the lead engineer at Focal Healthcare. His team built two FDA-cleared products for image-guided prostate therapy. Matt received his MEsc in biomedical engineering from Western.

Keith is VP of Business Development & Marketing at DURECT. He brings over 18 years of biopharma experience helping clinical stage programs transition to commercialization. Previously, he held roles in business development, strategy, and marketing at Oncopeptides, Prothena, Versartis, Pharmacyclics, and Genentech. Keith received his BA from UC Berkeley and MBA from Vanderbilt.

Andrew is the co-founder and former CTO of DeviantArt, the world’s largest digital art social network with over 45 million active users. He led his team in building the company’s infrastructure, enabling billions of images to be uploaded, viewed, and searched for.

Alyssa is an early stage operator with a background in biomedical engineering, finance, product, and regulatory. She was a senior business analyst at Capital One and an R&D engineer at Baylis Medical. She received her MS in biomedical engineering from UCalgary and MBA from Rotman.

Jay has over 20 years of experience in drug development, operations, and strategy across therapeutic areas including oncology, immunology, and neurology. He is the founder and CEO of Ensemble Clinical, an independent consulting firm. Previously, he was VP of Clinical Operations at Prothena Biosciences and, prior to that, worked at Pharmacyclics, Janssen, Elan, and Amgen. He received his BS in Psychological Biology from UCLA and his MS in Artificial Intelligence from Northwestern University.